Off-Label Use of Biologic Agents in the Treatment of...

Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab

G. Guhl, B. Díaz-Ley, J. Fernández-Herrera
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
99
Year:
2008
Language:
english
DOI:
10.1016/s1578-2190(08)70191-4
File:
PDF, 579 KB
english, 2008
Conversion to is in progress
Conversion to is failed